4YD Stock Overview
A nanotechnology company, develops, manufactures, and sells nanoporous silica particles for life science applications worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Nanologica AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 0.12 |
| 52 Week High | SEK 0.93 |
| 52 Week Low | SEK 0.12 |
| Beta | 0.39 |
| 11 Month Change | -42.48% |
| 3 Month Change | -69.69% |
| 1 Year Change | -86.22% |
| 33 Year Change | -89.91% |
| 5 Year Change | n/a |
| Change since IPO | -92.64% |
Recent News & Updates
Recent updates
Shareholder Returns
| 4YD | DE Biotechs | DE Market | |
|---|---|---|---|
| 7D | -10.6% | -0.7% | -0.02% |
| 1Y | -86.2% | -17.2% | 8.2% |
Return vs Industry: 4YD underperformed the German Biotechs industry which returned -17.2% over the past year.
Return vs Market: 4YD underperformed the German Market which returned 8.2% over the past year.
Price Volatility
| 4YD volatility | |
|---|---|
| 4YD Average Weekly Movement | 19.3% |
| Biotechs Industry Average Movement | 6.5% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.9% |
| 10% least volatile stocks in DE Market | 2.3% |
Stable Share Price: 4YD's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 4YD's weekly volatility has increased from 13% to 19% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 16 | Andreas Bhagwani | www.nanologica.com |
Nanologica AB (publ), a nanotechnology company, develops, manufactures, and sells nanoporous silica particles for life science applications worldwide. The company operates through two segments, Drug Development and Chromatography. It offers NLAB Saga, a new generation silica for preparative chromatography; and SVEA HPLC analytical columns.
Nanologica AB (publ) Fundamentals Summary
| 4YD fundamental statistics | |
|---|---|
| Market cap | €13.98m |
| Earnings (TTM) | -€7.69m |
| Revenue (TTM) | €762.10k |
18.3x
P/S Ratio-1.8x
P/E RatioIs 4YD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4YD income statement (TTM) | |
|---|---|
| Revenue | SEK 8.76m |
| Cost of Revenue | SEK 7.44m |
| Gross Profit | SEK 1.33m |
| Other Expenses | SEK 89.76m |
| Earnings | -SEK 88.43m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 07, 2025
| Earnings per share (EPS) | -1.00 |
| Gross Margin | 15.15% |
| Net Profit Margin | -1,009.07% |
| Debt/Equity Ratio | -0.3% |
How did 4YD perform over the long term?
See historical performance and comparison